CORRECTION article

Front. Immunol., 02 September 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1672972

Correction: Therapeutic potential of isochlorogenic acid A from Taraxacum officinale in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer

  • 1. Department of Basic Medical Sciences, Qinghai University Medical College, Xining, Qinghai, China

  • 2. Department of Medical Laboratory, Qinghai Provincial People’s Hospital, Xining, Qinghai, China

  • 3. State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, Qinghai, China

  • 4. Research Center for High Altitude Medicine, Qinghai University, Xining, Qinghai, China

  • 5. Key Laboratory of the Ministry of High Altitude Medicine, Qinghai University, Xining, Qinghai, China

There was a mistake in Figure 7F as published. The error was caused by the use of placeholder images during the typesetting process to maintain layout consistency; due to oversight, some placeholders were not replaced with the correct images. The corrected Figure 7F appears below.

Figure 7

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

immune checkpoint blockade, Taraxacum officinale, PD-1/PD-L1 inhibitor 2, tumor microenvironments, triple-negative breast cancer

Citation

Wang T, Sun J, Wang L, Lin Y, Wu Z, Jia Q, Zhang S, An J, Ma X, Wu Q, Su Z and Wang H (2025) Correction: Therapeutic potential of isochlorogenic acid A from Taraxacum officinale in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer. Front. Immunol. 16:1672972. doi: 10.3389/fimmu.2025.1672972

Received

25 July 2025

Accepted

27 August 2025

Published

02 September 2025

Volume

16 - 2025

Edited and reviewed by

Hridayesh Prakash, Amity University, India

Updates

Copyright

*Correspondence: Haiyan Wang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics